Ultrasound 'Key' may let chemo reach Kids' brain tumors
NCT ID NCT05293197
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests whether a device called SonoCloud-9 can safely open the blood-brain barrier in children aged 5 to 17 with recurrent malignant brain tumors. The barrier normally blocks chemotherapy from reaching the brain. By using low-intensity ultrasound just before giving the drug carboplatin, researchers hope to boost treatment effectiveness. The study involves 24 participants and focuses on safety, including risks like bleeding or seizures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- carboplatin (chemotherapy) delivered after ultrasound opening of the blood-brain barrier using the SonoCloud-9 device
- What this could lead to
- If it works, this could make chemotherapy more effective for children with hard-to-treat brain tumors by temporarily opening the blood-brain barrier.
- What could go wrong
- This is a very early (Phase 1) safety trial with only 24 children, so it may not improve survival. Risks include bleeding, brain swelling, or seizures from the ultrasound procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL TERATOID/RHABDOID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Curie
RECRUITINGParis, 75005, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
-
Service de neurochirugie Pédiatrique - Hôpital Necker- Enfants Malades
RECRUITINGParis, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can an AI app give a voice to brain tumor patients?
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- AI reads MRI scans to reveal hidden brain tumor types in children before surgery
- Targeted radiation zaps childhood brain tumors in early trial